1Intensive Care Unit, St John of God Hospital, Subiaco, Western Australia. hdnguyen@graduate.uwa.edu.au
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Levosimendan, a novel inotropic agent, effectively treated a patient with postpartum cardiomyopathy (PPCMO), improving cardiac performance and leading to recovery. This case highlights its potential as an initial therapy for PPCMO.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: